JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: GW842166X is a novel, potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM and with the potential for the treatment of inflammatory pain, it shows little activity on CB1 receptor. GW842166X shows similar potency and efficacy for rat and human recombinant CB2 receptors with EC50 of 91 nM and 63nM, respectively. GW-842166X exhibits full agonist potency with an EC50 of 133 nM and Emax of 101% in cyclase assays. IT exhibits weak agonist potency with an EC50 of 7.780 uM and Emax of 84% in FLIPR assays.
References: J Med Chem. 2007 May 31; 50(11):2597-600; Br J Pharmacol. 2008 Jan; 153(2):390-401
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!